BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17713457)

  • 21. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications.
    Monfort P; Cauli O; Montoliu C; Rodrigo R; Llansola M; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
    Neurochem Int; 2009; 55(1-3):106-12. PubMed ID: 19428813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotics can treat hepatic encephalopathy.
    Solga SF
    Med Hypotheses; 2003 Aug; 61(2):307-13. PubMed ID: 12888324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic prophylaxis in acute necrotizing pancreatitis revisited.
    Segarra-Newnham M; Hough A
    Ann Pharmacother; 2009 Sep; 43(9):1486-95. PubMed ID: 19690227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis].
    Klossek JM
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(3):187-92. PubMed ID: 18323331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    Johnson S
    J Infect; 2009 Jun; 58(6):403-10. PubMed ID: 19394704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common and alternate oral antibiotic therapies for acne vulgaris: a review.
    Amin K; Riddle CC; Aires DJ; Schweiger ES
    J Drugs Dermatol; 2007 Sep; 6(9):873-80. PubMed ID: 17941358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging therapies for diverticular disease of the colon.
    Trivedi CD; Das KM;
    J Clin Gastroenterol; 2008; 42(10):1145-51. PubMed ID: 18936655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of portocaval encephalopathy treatment with lactulose, lactobacilli and antibiotics].
    Imler M; Kurtz D; Bockel R; Stahl J
    Therapeutique; 1971 Mar; 47(3):237-48. PubMed ID: 4997495
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of oral zinc in hepatic encephalopathy remains unclear.
    Coughlan J; Hamlin PJ; Ford AC
    Aliment Pharmacol Ther; 2010 Dec; 32(11-12):1405-6; author reply 1406-7. PubMed ID: 21050244
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatic encephalopathy.
    Munoz SJ
    Med Clin North Am; 2008 Jul; 92(4):795-812, viii. PubMed ID: 18570943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ornithine aspartate in hepatic encephalopathy: an established new therapeutic approach. Overview and results of current randomized studies].
    Krüger B; Held C; Kircheis G
    Z Arztl Fortbild (Jena); 1994 Sep; 88(9):673-9. PubMed ID: 7975752
    [No Abstract]   [Full Text] [Related]  

  • 35. Minimal hepatic encephalopathy.
    Stewart CA; Smith GE
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):677-85. PubMed ID: 18043677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimal hepatic encephalopathy: time to recognise and treat.
    Dhiman RK; Chawla YK
    Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new use for Xifaxan.
    Belavic JM
    Nurse Pract; 2011 Jul; 36(7):8-9. PubMed ID: 21685772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors.
    Tan EH; Chan A
    Ann Pharmacother; 2009 Oct; 43(10):1658-66. PubMed ID: 19755624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic approach to persistent hepatic encephalopathy.
    Macías-Rodríguez RU; Torre A
    Rev Gastroenterol Mex; 2011; 76(4):345-52. PubMed ID: 22188960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.